136 related articles for article (PubMed ID: 10554886)
21. Investigation of the vasorelaxant effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole (YC-1) and diethylamine/nitric oxide (DEA/NO) on the human radial artery used as coronary bypass graft.
Berkan O; Bagcivan I; Kaya T; Yildirim K; Yildirim S; Doğan K
Can J Physiol Pharmacol; 2007 May; 85(5):521-6. PubMed ID: 17632587
[TBL] [Abstract][Full Text] [Related]
22. The design and synthesis of YC-1 analogues as probes for soluble guanylate cyclase.
Hering KW; Artz JD; Pearson WH; Marletta MA
Bioorg Med Chem Lett; 2006 Feb; 16(3):618-21. PubMed ID: 16326101
[TBL] [Abstract][Full Text] [Related]
23. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits the spontaneous contractions of isolated pregnant rat myometrium.
Cetin A; Kaya T; Demirkoprulu N; Karadas B; Duran B; Cetin M
J Pharmacol Sci; 2004 Jan; 94(1):19-24. PubMed ID: 14745113
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
Severina IS; Belushkina NN; Grigoryev NB
Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
[TBL] [Abstract][Full Text] [Related]
25. Ascorbate activates soluble guanylate cyclase via H2O2-metabolism by catalase.
Cherry PD; Wolin MS
Free Radic Biol Med; 1989; 7(5):485-90. PubMed ID: 2575561
[TBL] [Abstract][Full Text] [Related]
26. Synergistic interaction of adenylate cyclase activators and nitric oxide donor SIN-1 on platelet cyclic AMP.
Fisch A; Michael-Hepp J; Meyer J; Darius H
Eur J Pharmacol; 1995 May; 289(3):455-61. PubMed ID: 7556414
[TBL] [Abstract][Full Text] [Related]
27. Soluble guanylyl cyclase activator YC-1 inhibits human neutrophil functions through a cGMP-independent but cAMP-dependent pathway.
Hwang TL; Hung HW; Kao SH; Teng CM; Wu CC; Cheng SJ
Mol Pharmacol; 2003 Dec; 64(6):1419-27. PubMed ID: 14645672
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of platelet adhesion to collagen by cGMP-elevating agents.
Wu CC; Ko FN; Teng CM
Biochem Biophys Res Commun; 1997 Feb; 231(2):412-6. PubMed ID: 9070290
[TBL] [Abstract][Full Text] [Related]
29. Activation of guanylate cyclase by superoxide dismutase and hydroxyl radical: a physiological regulator of guanosine 3',5'-monophosphate formation.
Mittal CK; Murad F
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4360-4. PubMed ID: 22077
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of isoliquiritigenin and YC-1 in rat aortic smooth muscle.
Wegener JW; Nawrath H
Eur J Pharmacol; 1997 Mar; 323(1):89-91. PubMed ID: 9105881
[TBL] [Abstract][Full Text] [Related]
31. YC-1 activation of human soluble guanylyl cyclase has both heme-dependent and heme-independent components.
Martin E; Lee YC; Murad F
Proc Natl Acad Sci U S A; 2001 Nov; 98(23):12938-42. PubMed ID: 11687640
[TBL] [Abstract][Full Text] [Related]
32. Role of soluble guanylate cyclase in dilator responses of the cerebral microcirculation.
Faraci FM; Sobey CG
Brain Res; 1999 Mar; 821(2):368-73. PubMed ID: 10064823
[TBL] [Abstract][Full Text] [Related]
33. Derivatives of benzotetrazine-1,3-dioxide are new NO-donors, activators of soluble guanylate cyclase, and inhibitors of platelet aggregation.
Pyatakova NV; Khropov YV; Churakov AM; Tarasova NI; Serezhenkov VA; Vanin AF; Tartakovsky VA; Severina IS
Biochemistry (Mosc); 2002 Mar; 67(3):329-34. PubMed ID: 11970731
[TBL] [Abstract][Full Text] [Related]
34. [Nitric oxide. Potentiation of NO-dependent activation of soluble guanylate cyclase--(patho)physiological and pharmacotherapeutical significance].
Severina IS
Biomed Khim; 2007; 53(4):385-99. PubMed ID: 18035720
[TBL] [Abstract][Full Text] [Related]
35. An evolutionarily conserved mechanism for sensitization of soluble guanylyl cyclase reveals extensive nitric oxide-mediated upregulation of cyclic GMP in insect brain.
Ott SR; Delago A; Elphick MR
Eur J Neurosci; 2004 Sep; 20(5):1231-44. PubMed ID: 15341595
[TBL] [Abstract][Full Text] [Related]
36. Soluble guanylate cyclase: effect of YC-1 on ligation kinetics with carbon monoxide.
Sharma VS; Magde D; Kharitonov VG; Koesling D
Biochem Biophys Res Commun; 1999 Jan; 254(1):188-91. PubMed ID: 9920755
[TBL] [Abstract][Full Text] [Related]
37. Mechanism of YC-1-induced activation of soluble guanylyl cyclase.
Friebe A; Koesling D
Mol Pharmacol; 1998 Jan; 53(1):123-7. PubMed ID: 9443939
[TBL] [Abstract][Full Text] [Related]
38. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
Chirkov YY; Belushkina NN; Tyshchuk IA; Severina IS; Horowitz JD
Clin Exp Pharmacol Physiol; 1991 Jul; 18(7):517-24. PubMed ID: 1680588
[TBL] [Abstract][Full Text] [Related]
39. Molecular mechanisms involved in the synergistic activation of soluble guanylyl cyclase by YC-1 and nitric oxide in endothelial cells.
Schmidt K; Schrammel A; Koesling D; Mayer B
Mol Pharmacol; 2001 Feb; 59(2):220-4. PubMed ID: 11160856
[TBL] [Abstract][Full Text] [Related]
40. [Potentiation of NO-dependent activation of soluble guanylate cyclase by polyamines].
Severina IS; Piatakova NV; Shchegolev AIu
Biomed Khim; 2007; 53(1):44-9. PubMed ID: 17436683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
